Fennec Pharmaceuticals (FENC) News Today $5.09 +0.45 (+9.70%) (As of 12:50 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Fennec Pharmaceuticals (NASDAQ:FENC) Rating Increased to Strong-Buy at StephensStephens raised Fennec Pharmaceuticals to a "strong-buy" rating in a research note on Monday.November 20 at 6:14 AM | marketbeat.comFennec initiated with an Overweight at StephensNovember 18 at 11:16 PM | markets.businessinsider.comFennec Pharmaceuticals to Participate in Upcoming Investor ConferenceNovember 13, 2024 | globenewswire.comFennec Pharmaceuticals Inc. (NASDAQ:FENC) Q3 2024 Earnings Call TranscriptNovember 11, 2024 | msn.comResearch Analysts Offer Predictions for FENC FY2025 EarningsFennec Pharmaceuticals Inc (NASDAQ:FENC - Free Report) - Research analysts at Wedbush cut their FY2025 earnings estimates for shares of Fennec Pharmaceuticals in a note issued to investors on Thursday, November 7th. Wedbush analyst D. Nierengarten now anticipates that the company will earn $0.05November 11, 2024 | marketbeat.comFennec Pharmaceuticals (NASDAQ:FENC) Given "Outperform" Rating at WedbushNovember 11, 2024 | americanbankingnews.comFennec Pharmaceuticals Inc. (FENC) Q3 2024 Earnings Call TranscriptNovember 9, 2024 | seekingalpha.comFennec Pharmaceuticals Inc (FENC) Q3 2024 Earnings Call Highlights: Strong Sales Growth and ...November 9, 2024 | finance.yahoo.comFennec Pharmaceuticals Reports Q3 2024 Financial ResultsNovember 9, 2024 | markets.businessinsider.comFennec Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business UpdateNovember 7, 2024 | globenewswire.comInsider Selling: Fennec Pharmaceuticals Inc (NASDAQ:FENC) Director Sells 2,431 Shares of StockNovember 5, 2024 | insidertrades.comFennec Pharmaceuticals (FENC) Scheduled to Post Quarterly Earnings on ThursdayFennec Pharmaceuticals (NASDAQ:FENC) will be releasing earnings before the market opens on Thursday, November 7, Zacks reports.November 1, 2024 | marketbeat.comFennec Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 7, 2024October 31, 2024 | globenewswire.comFennec Pharmaceuticals Strengthens Executive Leadership Team with Three Key Appointments to Accelerate the Company’s Next Stage of GrowthOctober 28, 2024 | markets.businessinsider.comFennec Pharmaceuticals Appoints CMO, CCO, And CSOOctober 28, 2024 | markets.businessinsider.comFennec Pharmaceuticals Strengthens Executive Leadership Team with Three Key Appointments to Accelerate the Company's Next Stage of GrowthOctober 28, 2024 | globenewswire.comQ3 EPS Estimates for FENC Boosted by Capital One FinancialFennec Pharmaceuticals Inc (NASDAQ:FENC - Free Report) - Analysts at Capital One Financial lifted their Q3 2024 earnings per share estimates for Fennec Pharmaceuticals in a report issued on Wednesday, October 16th. Capital One Financial analyst N. Quibria now forecasts that the company will earnOctober 21, 2024 | marketbeat.comFennec: Operational Challenges Persist Despite Improved Financial PositionOctober 7, 2024 | seekingalpha.comFennec Pharmaceuticals (NASDAQ:FENC) Stock Quotes, Forecast and News SummaryOctober 5, 2024 | benzinga.comFennec Pharmaceuticals Inc (NASDAQ:FENC) Director Sells $12,009.14 in StockOctober 2, 2024 | insidertrades.comThe past three years for Fennec Pharmaceuticals (NASDAQ:FENC) investors has not been profitableOctober 1, 2024 | finance.yahoo.comFennec Pharmaceuticals (NASDAQ:FENC) Stock Price Down 4.9%Fennec Pharmaceuticals (NASDAQ:FENC) Shares Down 4.9%September 17, 2024 | marketbeat.comFennec Pharmaceuticals to Participate in Upcoming Investor ConferencesSeptember 5, 2024 | globenewswire.comFennec Pharmaceuticals Inc (RV41.BE)August 30, 2024 | finance.yahoo.comResearch Analysts Set Expectations for Fennec Pharmaceuticals Inc's FY2024 Earnings (NASDAQ:FENC)Fennec Pharmaceuticals Inc (NASDAQ:FENC - Free Report) - Cantor Fitzgerald dropped their FY2024 earnings per share (EPS) estimates for Fennec Pharmaceuticals in a research report issued to clients and investors on Thursday, August 22nd. Cantor Fitzgerald analyst C. Duncan now expects that the comAugust 26, 2024 | marketbeat.comBuy Rating Affirmed for Fennec Pharmaceuticals Amidst PEDMARK’s Long-Term Growth PotentialAugust 22, 2024 | markets.businessinsider.comFennec Pharmaceuticals (NASDAQ:FENC) Price Target Cut to $13.00 by Analysts at HC WainwrightHC Wainwright decreased their price objective on shares of Fennec Pharmaceuticals from $15.00 to $13.00 and set a "buy" rating for the company in a report on Thursday.August 22, 2024 | marketbeat.comFennec Pharmaceuticals Inc. (NASDAQ:FENC) Analysts Are Reducing Their Forecasts For This YearAugust 21, 2024 | finance.yahoo.comCapital One Financial Research Analysts Cut Earnings Estimates for Fennec Pharmaceuticals Inc (NASDAQ:FENC)Fennec Pharmaceuticals Inc (NASDAQ:FENC - Free Report) - Stock analysts at Capital One Financial decreased their Q3 2024 earnings per share estimates for Fennec Pharmaceuticals in a report released on Tuesday, August 13th. Capital One Financial analyst N. Quibria now forecasts that the company wiAugust 16, 2024 | marketbeat.comFennec Pharmaceuticals Second Quarter 2024 Earnings: Misses ExpectationsAugust 15, 2024 | uk.finance.yahoo.comFennec Pharmaceuticals (NASDAQ:FENC) Releases Earnings Results, Misses Expectations By $0.26 EPSFennec Pharmaceuticals (NASDAQ:FENC - Get Free Report) released its quarterly earnings data on Tuesday. The company reported ($0.20) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.06 by ($0.26). The business had revenue of $7.26 million for the quarter, compared to analyst estimates of $13.67 million. Fennec Pharmaceuticals had a negative return on equity of 39.41% and a net margin of 6.33%. During the same period in the prior year, the company posted ($0.21) earnings per share.August 15, 2024 | marketbeat.comFY2027 Earnings Estimate for Fennec Pharmaceuticals Inc (NASDAQ:FENC) Issued By Capital One FinancialFennec Pharmaceuticals Inc (NASDAQ:FENC - Free Report) - Stock analysts at Capital One Financial lowered their FY2027 earnings per share (EPS) estimates for Fennec Pharmaceuticals in a research note issued to investors on Tuesday, August 13th. Capital One Financial analyst N. Quibria now anticipaAugust 15, 2024 | marketbeat.comBuy Rating for Fennec Pharmaceuticals Bolstered by Pedmark’s Market Expansion and New LeadershipAugust 15, 2024 | markets.businessinsider.comVanguard Group Inc. Sells 126,437 Shares of Fennec Pharmaceuticals Inc (NASDAQ:FENC)Vanguard Group Inc. trimmed its stake in Fennec Pharmaceuticals Inc (NASDAQ:FENC - Free Report) by 11.1% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,013,626 shares of the company's stock afterAugust 15, 2024 | marketbeat.comOptimistic Buy Rating for Fennec Pharmaceuticals Amidst Pedmark’s Market Expansion and Strong Financial OutlookAugust 15, 2024 | markets.businessinsider.comQ2 2024 Fennec Pharmaceuticals Inc Earnings Call TranscriptAugust 14, 2024 | gurufocus.comFennec Pharmaceuticals Inc (FENC) Q2 2024 Earnings Call Transcript Highlights: Strong Revenue ...August 14, 2024 | gurufocus.comCraig Hallum Trims Fennec Pharmaceuticals (NASDAQ:FENC) Target Price to $15.00Craig Hallum decreased their price target on shares of Fennec Pharmaceuticals from $17.00 to $15.00 and set a "buy" rating for the company in a research note on Wednesday.August 14, 2024 | marketbeat.comFennec Pharmaceuticals Inc (NASDAQ:FENC) Expected to Earn FY2026 Earnings of $2.31 Per ShareFennec Pharmaceuticals Inc (NASDAQ:FENC - Free Report) - Research analysts at Wedbush lowered their FY2026 earnings estimates for shares of Fennec Pharmaceuticals in a report released on Tuesday, August 13th. Wedbush analyst D. Nierengarten now anticipates that the company will post earnings of $August 14, 2024 | marketbeat.comQ2 2024 Fennec Pharmaceuticals Inc Earnings CallAugust 14, 2024 | finance.yahoo.comWedbush Reiterates Outperform Rating for Fennec Pharmaceuticals (NASDAQ:FENC)Wedbush reiterated an "outperform" rating and set a $14.00 target price (down previously from $16.00) on shares of Fennec Pharmaceuticals in a research report on Tuesday.August 13, 2024 | marketbeat.comFennec Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business UpdateAugust 13, 2024 | globenewswire.comBuy Rating Affirmed Amid Leadership Transition and Strong Growth Prospects for Fennec PharmaceuticalsAugust 7, 2024 | markets.businessinsider.comFennec Pharmaceuticals names new CEO to expand PEDMARK reachAugust 7, 2024 | investing.comFennec Pharmaceuticals (FENC) to Release Earnings on TuesdayFennec Pharmaceuticals (NASDAQ:FENC) will be releasing earnings before the market opens on Tuesday, August 13, Zacks reports.August 7, 2024 | marketbeat.comFennec Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 13, 2024August 6, 2024 | globenewswire.comPublicly traded NC company replaces veteran CEO amid shakeupAugust 6, 2024 | bizjournals.comNorth Carolina public company replaces CEO amid shakeupAugust 6, 2024 | bizjournals.comBuy Rating Affirmed for Fennec Pharmaceuticals Amidst Leadership Change and Market Opportunity ExpansionAugust 6, 2024 | markets.businessinsider.comFennec Pharmaceuticals Appoints Jeffrey S. Hackman as Chief Executive Officer and DirectorAugust 5, 2024 | globenewswire.com Get Fennec Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for FENC and its competitors with MarketBeat's FREE daily newsletter. Email Address Blackrock’s Sending THIS Crypto Higher on Purpose (Ad)It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development… YES, I WANT THE #1 CRYPTO NOW FENC Media Mentions By Week FENC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. FENC News Sentiment▼0.610.47▲Average Medical News Sentiment FENC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. FENC Articles This Week▼32▲FENC Articles Average Week Get Fennec Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for FENC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Sana Biotechnology News Monte Rosa Therapeutics News ProKidney News MeiraGTx News REGENXBIO News Taysha Gene Therapies News Aura Biosciences News Allogene Therapeutics News Sangamo Therapeutics News Prime Medicine News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:FENC) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fennec Pharmaceuticals Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Fennec Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
